Diabetic macular oedema quantified with spectral-domain optical coherence tomography - evaluation of boundary line artefacts and the effect on retinal thickness-Reference-Cited by-同舟云学术

Diabetic macular oedema quantified with spectral-domain optical coherence tomography - evaluation of boundary line artefacts and the effect on retinal thickness

Published:2014-07-10 Issue:1 Volume:93 Page:74-82
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmol

Author:

Hodzic-Hadzibegovic Delila¹²,Sander Birgit A.¹,Lund-Andersen Henrik¹²³

Affiliation:

1. Department of Ophthalmology; Glostrup Hospital; University of Copenhagen; Glostrup Denmark

2. Faculty of Health Sciences; University of Copenhagen; Copenhagen Denmark

3. Steno Diabetes Center; Gentofte Denmark

Funder

The Fight for Sight, Denmark

The Synoptik Foundation, Denmark

The VELUX Foundation, Denmark

Glostrup Hospital, Copenhagen, Denmark

Novartis

Bayer

Pfizer

Alcon

GlaxoSmithKline

Allergan

Eli Lilly

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Reference26 articles.

1. Reliability, repeatability and reproducibility: analysis of measurement errors in continuous variables;Bartlett;Ultrasound Obstet Gynecol,2008

2. Diabetic macular edema: pathogenesis and treatment;Bhagat;Surv Ophthalmol,2009

3. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE;Brown;Ophthalmology,2013

4. Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography;Browning;Ophthalmology,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LONG-TERM VISUAL OUTCOMES AND OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION FOLLOWING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY;Retina;2024-09

2. Imaging biomarkers and clinical factors associated with the rate of progressive inner and outer retinal thinning in patients with diabetic macular edema;Scientific Reports;2023-02-24

3. Microvascular Changes After Conbercept Intravitreal Injection of PDR With or Without Center-Involved Diabetic Macular Edema Analyzed by OCTA;Frontiers in Medicine;2022-03-22

4. Long-Term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes With Diabetic Macular Edema Treated With Anti-VEGF Therapy;American Journal of Ophthalmology;2022-03

5. Association of metformin treatment with enhanced effect of anti-VEGF agents in diabetic macular edema patients;Acta Diabetologica;2022-01-16